{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:05:55Z","timestamp":1785150355864,"version":"3.55.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.hlc.2025.08.003","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:58:45Z","timestamp":1756961925000},"page":"1021-1032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Obesity and Atrial Fibrillation: From Mechanisms to Treatment"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0139-4254","authenticated-orcid":false,"given":"Jenelle K.","family":"Dziano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Ariyaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-4239","authenticated-orcid":false,"given":"Adrian D.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2025.08.003_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41569-023-00847-5","article-title":"Obesity and the risk of cardiometabolic diseases","volume":"20","author":"Valenzuela","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","author":"Ng","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2025.08.003_bib3","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5694\/mja14.00238","article-title":"Estimating the current and future prevalence of atrial fibrillation in the Australian adult population","volume":"202","author":"Ball","year":"2015","journal-title":"Med J Aust"},{"key":"10.1016\/j.hlc.2025.08.003_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib6","article-title":"Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study","volume":"361","author":"Staerk","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.hlc.2025.08.003_bib7","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1093\/eurheartj\/ehad615","article-title":"Acquired risk factors and incident atrial fibrillation according to age and genetic predisposition","volume":"44","author":"Wang","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2025.08.003_bib8","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1001\/archinte.166.21.2322","article-title":"Risk of new-onset atrial fibrillation in relation to body mass index","volume":"166","author":"Dublin","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hlc.2025.08.003_bib9","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.jacc.2010.11.045","article-title":"Pericardial fat is associated with atrial fibrillation severity and ablation outcome","volume":"57","author":"Wong","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib10","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2025.08.003_bib11","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/eurheartj\/ehn324","article-title":"Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years","volume":"29","author":"Tsang","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2025.08.003_bib12","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jacc.2007.06.054","article-title":"Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data","volume":"50","author":"Issac","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccep.2020.11.012","article-title":"Autonomic dysfunction and neurohormonal disorders in atrial fibrillation","volume":"13","author":"Pfenniger","year":"2021","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.hlc.2025.08.003_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.hrthm.2012.08.043","article-title":"Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation","volume":"10","author":"Abed","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2025.08.003_bib15","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2025.08.003_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4065\/76.5.467","article-title":"Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women","volume":"76","author":"Tsang","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hlc.2025.08.003_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004299","article-title":"Cardiac magnetic resonance\u2013measured left atrial volume and function and incident atrial fibrillation: results from MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"9","author":"Habibi","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2025.08.003_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jacc.2012.03.042","article-title":"Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation","volume":"60","author":"Munger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jcmg.2009.10.012","article-title":"The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"3","author":"Turkbey","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2025.08.003_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/CIRCULATIONAHA.109.885806","article-title":"Longitudinal tracking of left atrial diameter over the adult life course: clinical correlates in the community","volume":"121","author":"McManus","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.003_bib21","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1253\/circj.CJ-11-0554","article-title":"Association between epicardial adipose tissue volumes on 3-dimensional reconstructed CT images and recurrence of atrial fibrillation after catheter ablation","volume":"75","author":"Nagashima","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.hlc.2025.08.003_bib22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ehjci\/jeu006","article-title":"Association of epicardial adipose tissue and left atrial size on non-contrast CT with atrial fibrillation: the Heinz Nixdorf Recall Study","volume":"15","author":"Mahabadi","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2025.08.003_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/cvr\/cvu045","article-title":"Epicardial adipose tissue and atrial fibrillation","volume":"102","author":"Hatem","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hlc.2025.08.003_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","article-title":"Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines","volume":"36","author":"Venteclef","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2025.08.003_bib25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jacc.2020.07.017","article-title":"Epicardial adipose tissue accumulation confers atrial conduction abnormality","volume":"76","author":"Nalliah","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib26","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1161\/CIRCULATIONAHA.120.052009","article-title":"Extracellular vesicles from epicardial fat facilitate atrial fibrillation","volume":"143","author":"Shaihov-Teper","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.003_bib27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jacep.2020.11.015","article-title":"Atrial fibrillation and obesity: reverse remodeling of atrial substrate with weight reduction","volume":"7","author":"Mahajan","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib28","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.003_bib29","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.003_bib30","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.107.710509","article-title":"Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study","volume":"116","author":"Pou","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.003_bib31","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hlc.2025.08.003_bib32","first-page":"4196","article-title":"Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-\u03b1, in vivo","volume":"82","author":"Mohamed-Ali","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2025.08.003_bib33","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hlc.2025.08.003_bib34","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hlc.2025.08.003_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.hlc.2025.08.003_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011006","article-title":"Systemic inflammation rapidly induces reversible atrial electrical remodeling: the role of interleukin-6\u2013mediated changes in connexin expression","volume":"8","author":"Lazzerini","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2025.08.003_bib37","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2022.03.379","article-title":"Inflammasome signaling in atrial fibrillation: JACC state-of-the-art review","volume":"79","author":"Ajoolabady","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib38","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/cvr\/cvab024","article-title":"NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias","volume":"117","author":"Scott","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hlc.2025.08.003_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0895-7061(97)00053-8","article-title":"Plasma angiotensinogen concentrations in obese patients","volume":"10","author":"Umemura","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hlc.2025.08.003_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/j.1550-8528.1999.tb00418.x","article-title":"Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women","volume":"7","author":"Goodfriend","year":"1999","journal-title":"Obes Res"},{"key":"10.1016\/j.hlc.2025.08.003_bib41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2025.08.003_bib42","first-page":"197","article-title":"The link between adipose tissue renin-angiotensin-aldosterone system signaling and obesity-associated hypertension","volume":"32","author":"Sch\u00fctten","year":"2017","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.hlc.2025.08.003_bib43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacep.2017.03.002","article-title":"Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation","volume":"3","author":"Nattel","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib44","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.HYP.17.5.669","article-title":"Relation of obesity and diet to sympathetic nervous system activity","volume":"17","author":"Troisi","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2025.08.003_bib45","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/00004872-200412000-00019","article-title":"Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives","volume":"22","author":"Grassi","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2025.08.003_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2018.11.091","article-title":"Role of autonomic nervous system in atrial fibrillation","volume":"287","author":"Linz","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib47","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.HYP.0000066289.17754.49","article-title":"Interactions between leptin and the human sympathetic nervous system","volume":"41","author":"Eikelis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2025.08.003_bib48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2362.2008.02028.x","article-title":"Effect of obesity and insulin sensitivity on adiponectin isoform distribution","volume":"38","author":"Kaser","year":"2008","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.hlc.2025.08.003_bib49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/HYPERTENSIONAHA.107.099424","article-title":"Adiponectin, cardiovascular function, and hypertension","volume":"51","author":"Wang","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2025.08.003_bib50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCEP.112.971200","article-title":"Does location of epicardial adipose tissue correspond to endocardial high dominant frequency or complex fractionated atrial electrogram sites during atrial fibrillation?","volume":"5","author":"Nagashima","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.04.058","article-title":"Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity","volume":"66","author":"Mahajan","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib52","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jacep.2018.08.014","article-title":"Electroanatomical remodeling of the atria in obesity: impact of adjacent epicardial fat","volume":"4","author":"Mahajan","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib53","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.hlc.2025.08.003_bib54","article-title":"Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study: Danish","volume":"385","author":"Vinter","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.hlc.2025.08.003_bib55","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","article-title":"Epidemiology and modifiable risk factors for atrial fibrillation","volume":"20","author":"Elliott","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib56","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/heartjnl-2021-320131","article-title":"Prevalence, incidence and survival of heart failure: a systematic review","volume":"108","author":"Emmons-Bell","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.hlc.2025.08.003_bib57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.003_bib58","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","article-title":"The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.003_bib59","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.003_bib60","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.003_bib61","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hroo.2021.09.015","article-title":"Heart failure with preserved ejection fraction: an alternative paradigm to explain the clinical implications of atrial fibrillation","volume":"2","author":"Ariyaratnam","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2025.08.003_bib62","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jchf.2023.07.019","article-title":"Identification of subclinical heart failure with preserved ejection fraction in patients with symptomatic atrial fibrillation","volume":"11","author":"Ariyaratnam","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.003_bib63","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.117.030093","article-title":"High prevalence of occult heart failure with preserved ejection fraction among patients with atrial fibrillation and dyspnea","volume":"137","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.003_bib64","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","article-title":"Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study","volume":"388","author":"O'Donnell","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2025.08.003_bib65","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.46613","article-title":"Adiposity, body fat distribution, and risk of major stroke types among adults in the United Kingdom","volume":"5","author":"Pillay","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hlc.2025.08.003_bib66","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/STROKEAHA.117.020059","article-title":"Atrial cardiopathy and the risk of ischemic stroke in the CHS (cardiovascular health study)","volume":"49","author":"Kamel","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.hlc.2025.08.003_bib67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-7435(87)90087-9","article-title":"Incidence and precursors of hypertension in young adults: the Framingham Offspring Study","volume":"16","author":"Garrison","year":"1987","journal-title":"Prev Med"},{"key":"10.1016\/j.hlc.2025.08.003_bib68","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000110","article-title":"Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry","volume":"2","author":"Fosbol","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2025.08.003_bib69","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.hrthm.2010.05.010","article-title":"Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model","volume":"7","author":"Lau","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2025.08.003_bib70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMp068177","article-title":"Obesity and diabetes in the developing world\u2014a growing challenge","volume":"356","author":"Hossain","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.003_bib71","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1540-8167.2006.00528.x","article-title":"What are arrhythmogenic substrates in diabetic rat atria?","volume":"17","author":"Kato","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib72","first-page":"543","volume":"12","author":"Liu","year":"2012","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib73","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10840-012-9722-1","article-title":"Atrial conduction time and atrial mechanical function in patients with impaired fasting glucose","volume":"35","author":"Ayhan","year":"2012","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib74","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1536\/ihj.50.627","article-title":"Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart","volume":"50","author":"Otake","year":"2009","journal-title":"Int Heart J"},{"key":"10.1016\/j.hlc.2025.08.003_bib75","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.amjcard.2010.07.038","article-title":"Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose","volume":"106","author":"Chao","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib76","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jacc.2015.10.080","article-title":"Effect of diabetes and glycemic control on ischemic stroke risk in AF patients: ATRIA study","volume":"67","author":"Ashburner","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib77","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1378\/chest.09-0360","article-title":"Interactions between obesity and obstructive sleep apnea: implications for treatment","volume":"137","author":"Romero-Corral","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2025.08.003_bib78","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/aje\/154.1.50","article-title":"Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study","volume":"154","author":"Newman","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib79","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.5665\/sleep.4072","article-title":"Tongue fat and its relationship to obstructive sleep apnea","volume":"37","author":"Kim","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.hlc.2025.08.003_bib80","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jamacardio.2018.0095","article-title":"Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a review","volume":"3","author":"Linz","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib81","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2006.08.060","article-title":"Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib82","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2010.02.029","article-title":"The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation: the WHS (Women's Health Study)","volume":"55","author":"Tedrow","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib83","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib84","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive Effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hlc.2025.08.003_bib85","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib88","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/europace\/euab122","article-title":"Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial","volume":"23","author":"Gessler","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hlc.2025.08.003_bib89","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/jce.13394","article-title":"Impact of weight loss on ablation outcome in obese patients with longstanding persistent atrial fibrillation","volume":"29","author":"Mohanty","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacc.2025.04.042","article-title":"Catheter ablation vs lifestyle modification with antiarrhythmic drugs to treat atrial fibrillation: PRAGUE-25 trial","volume":"86","author":"Osmancik","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib91","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2016.09.940","article-title":"Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects","volume":"68","author":"Jamaly","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib92","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007626","article-title":"Impact of bariatric surgery on atrial fibrillation type","volume":"13","author":"Donnellan","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib101","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.jacep.2024.03.031","article-title":"Effects of glucagon-like peptide-1 receptor agonists on atrial fibrillation recurrence after catheter ablation","volume":"10","author":"Satti","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib86","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/jce.14607","article-title":"Impact of risk-factor modification on arrhythmia recurrence among morbidly obese patients undergoing atrial fibrillation ablation","volume":"31","author":"Donnellan","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"25","key":"10.1016\/j.hlc.2025.08.003_bib87","first-page":"e728","volume":"150","author":"Pathak","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.003_bib93","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like Peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.hlc.2025.08.003_bib94","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.003_bib95","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.003_bib96","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.003_bib97","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.003_bib98","doi-asserted-by":"crossref","first-page":"S542","DOI":"10.1016\/j.hrthm.2024.03.1380","article-title":"PO-05-145 glucagon-like PEPTIDE-1 receptor agonist in patients undergoing atrial fibrillation ablation: a matched analysis","volume":"21","author":"Tabaja","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2025.08.003_bib99","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.hrthm.2024.03.334","article-title":"CE-482907-002 impact of GLP-1 agonists in patients with atrial fibrillation ablation","volume":"21","author":"Sheth","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2025.08.003_bib100","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.hrthm.2024.03.1802","article-title":"MP-483498-003 semaglutide and atrial fibrillation recurrence after catheter ablation","volume":"21","author":"Zou","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2025.08.003_bib102","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2025.08.003_bib103","doi-asserted-by":"crossref","first-page":"bvz042","DOI":"10.1210\/jendso\/bvz042","article-title":"Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity","volume":"4","author":"Iacobellis","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.hlc.2025.08.003_bib104","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.003_bib105","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin-angiotensin-aldosterone system","volume":"45","author":"Engeli","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2025.08.003_bib106","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1210\/jc.2005-0961","article-title":"Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome","volume":"90","author":"Straznicky","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2025.08.003_bib107","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2019.04.019","article-title":"Hemodynamic effects of weight loss in obesity: a systematic review and meta-analysis","volume":"7","author":"Reddy","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.003_bib108","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.003_bib109","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2025.08.003_bib110","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.003_bib111","volume":"2024","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2025.08.003_bib112","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.hlc.2023.12.024","article-title":"2023 Cardiac Society of Australia and New Zealand expert position statement on catheter and surgical ablation for atrial fibrillation","volume":"33","author":"Kistler","year":"2024","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2025.08.003_bib113","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.hlc.2024.08.008","article-title":"Research priorities for atrial fibrillation in Australia: A statement from the Australian cardiovascular alliance clinical arrhythmia theme","volume":"33","author":"Elliott","year":"2024","journal-title":"Heart Lung Circ"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950625015744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950625015744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:29:50Z","timestamp":1759793390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950625015744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":113,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1443950625015744"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2025.08.003","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity and Atrial Fibrillation: From Mechanisms to Treatment","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2025.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}